Position history for BAKER BROS. ADVISORS LP's holdings in ARROWHEAD PHARMACEUTICALS IN
BAKER BROS. ADVISORS LP holds 2.2M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $144.4M as of 2025-Q4. The position was increased (++30.2% shares). ARWR represents 0.8% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$144.4M
Current Shares
2.2M
Total Value Change
+$129.6M
Total Shares Change
+1.2M
Other major holders of ARWR: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BANQUE PICTET & CIE SA
Increased |
| 2.2M |
+30.2% |
| $144.4M |
| 0.8% |
| $67.25 |
54 |
| 2025-Q3 | Increased | 1.7M | +77.9% | $57.6M | 0.4% | $33.78 | 54 |
| 2025-Q2 | New | 939,174 | - | $14.8M | 0.1% | $16.08 | 47 |